Background: Gestational environmental perturbations can induce sex-specific developmental programming, increasing offspring susceptibility to chronic diseases. While prenatal high estradiol (HE) exposure has been associated with male-biased neurodevelopmental disorders, the underlying mechanisms remain poorly understood.
Methods: Using spatial transcriptomics in a murine HE exposure model, we systematically characterized sex-divergent molecular and cellular responses in fetal brains. Through cell type identification, spatial mapping, ligand-receptor interaction analysis, and transcription factor activity assessment, we examined gene expression profile, intra-regional signaling pathway, and regulon activity variations. Additionally, we performed immunofluorescence to characterize neural progenitor cell dynamics.
Results: Our analysis revealed that maternal HE exposure differentially altered gene expression patterns between male and female fetal brain regions, with more pronounced effects on male-biased genes. Notably, HE-induced downregulation of male-biased genes was proportional to their baseline male-bias degree. We uncovered region-specific cellular responses to HE exposure and demonstrated sex-opposed alterations in intra-regional signaling pathway. Furthermore, we identified cell type- and brain region-restricted sex differences in regulon activity variations. Histological validation confirmed that maternal HE exposure specifically disrupts the proliferation-differentiation balance of neural progenitor cells in the male cerebral cortex.
Conclusions: These findings provide mechanistic insights into sex-dimorphic developmental reprogramming of fetal brain by maternal estradiol excess. They establish a framework for developing targeted interventions against gestational endocrine disruption-induced neurodevelopmental disorders.
{"title":"Sex-dimorphic reprogramming of fetal mouse brain development by maternal estradiol excess.","authors":"Huihui Wang, Zhe Wei, Yu Zhang, Xiaojun Chen, Li Jin, Chengliang Zhou","doi":"10.1186/s13293-025-00792-7","DOIUrl":"10.1186/s13293-025-00792-7","url":null,"abstract":"<p><strong>Background: </strong>Gestational environmental perturbations can induce sex-specific developmental programming, increasing offspring susceptibility to chronic diseases. While prenatal high estradiol (HE) exposure has been associated with male-biased neurodevelopmental disorders, the underlying mechanisms remain poorly understood.</p><p><strong>Methods: </strong>Using spatial transcriptomics in a murine HE exposure model, we systematically characterized sex-divergent molecular and cellular responses in fetal brains. Through cell type identification, spatial mapping, ligand-receptor interaction analysis, and transcription factor activity assessment, we examined gene expression profile, intra-regional signaling pathway, and regulon activity variations. Additionally, we performed immunofluorescence to characterize neural progenitor cell dynamics.</p><p><strong>Results: </strong>Our analysis revealed that maternal HE exposure differentially altered gene expression patterns between male and female fetal brain regions, with more pronounced effects on male-biased genes. Notably, HE-induced downregulation of male-biased genes was proportional to their baseline male-bias degree. We uncovered region-specific cellular responses to HE exposure and demonstrated sex-opposed alterations in intra-regional signaling pathway. Furthermore, we identified cell type- and brain region-restricted sex differences in regulon activity variations. Histological validation confirmed that maternal HE exposure specifically disrupts the proliferation-differentiation balance of neural progenitor cells in the male cerebral cortex.</p><p><strong>Conclusions: </strong>These findings provide mechanistic insights into sex-dimorphic developmental reprogramming of fetal brain by maternal estradiol excess. They establish a framework for developing targeted interventions against gestational endocrine disruption-induced neurodevelopmental disorders.</p>","PeriodicalId":8890,"journal":{"name":"Biology of Sex Differences","volume":" ","pages":"1"},"PeriodicalIF":5.1,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12777311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145660164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1186/s13293-025-00790-9
Wei Song, Samantha D Creighton, Bernadeta Michalski, Juliette Mojgani, Minesh Kapadia, Donglai Ma, Boris Sakic, Iva B Zovkic, Margaret Fahnestock
Background: Sex-dependent differences in prevalence and severity are characteristics of Alzheimer's disease (AD). Using the 3×Tg-AD mouse model, we previously reported that adult males show early behavioral dysfunction, altered epigenetic factors and lack of plaque/tangle pathology. Conversely, adult females retain more severe AD-like pathology and behavior. The present study examines whether gonadal hormones play a role in these differences in current cohorts of 3×Tg-AD mice.
Methods: 3×Tg-AD and wild-type mice were gonadectomized or sham-operated at 3 months of age. After behavioral phenotyping at 6 months of age, the animals were assessed for molecular markers of AD pathology and expression of genes and histone variants associated with neurodegeneration.
Results: In female transgenic (AD) mice, gonadectomy resulted in poorer spatial learning performance. In contrast, in transgenic male animals, gonadectomy improved spatial learning and memory. Compared to sham-operated AD females, gonadectomized AD females exhibited enhanced expression of mouse (m) Mapt and App genes, consistent with reduced binding activity of the repressive histone variant macroH2A1 at the mMapt gene, but there was no effect on Aβ42 or pTau181 levels. In contrast, gonadectomized AD males showed significantly increased macroH2A1 binding at the mPsen1 promoter, reduced expression of the App and MacroH2A1 genes, and reduced cortical soluble Aβ42 levels compared to sham-operated AD males.
Conclusions: In sum, the results suggest that reduction in serum levels of female gonadal hormones impairs spatial learning capacity, whereas loss of male gonadal hormones enhances spatial learning and memory. In females, gonadectomy reduces binding of the repressive histone variant MacroH2A1 to the mouse Mapt gene and increases expression of the mouse App and Mapt genes without affecting Aβ42 or pTau181 levels. Conversely, loss of male gonadal hormones increases binding of MacroH2A1 to the mouse Psen1 gene and decreases App expression and Aβ42 levels but has no effect on tau expression. Our work suggests that adult gonadal hormones contribute to sex differences in AD-like pathology and performance in learning and memory tasks. Moreover, sex-specific differences in AD-like pathology are partially due to the action of histone variants associated with neurodegeneration, such as macroH2A1.
{"title":"Gonadal hormones contribute to sex differences in behavior, pathology and epigenetic modifications in the 3×Tg-AD mouse model of Alzheimer's disease.","authors":"Wei Song, Samantha D Creighton, Bernadeta Michalski, Juliette Mojgani, Minesh Kapadia, Donglai Ma, Boris Sakic, Iva B Zovkic, Margaret Fahnestock","doi":"10.1186/s13293-025-00790-9","DOIUrl":"10.1186/s13293-025-00790-9","url":null,"abstract":"<p><strong>Background: </strong>Sex-dependent differences in prevalence and severity are characteristics of Alzheimer's disease (AD). Using the 3×Tg-AD mouse model, we previously reported that adult males show early behavioral dysfunction, altered epigenetic factors and lack of plaque/tangle pathology. Conversely, adult females retain more severe AD-like pathology and behavior. The present study examines whether gonadal hormones play a role in these differences in current cohorts of 3×Tg-AD mice.</p><p><strong>Methods: </strong>3×Tg-AD and wild-type mice were gonadectomized or sham-operated at 3 months of age. After behavioral phenotyping at 6 months of age, the animals were assessed for molecular markers of AD pathology and expression of genes and histone variants associated with neurodegeneration.</p><p><strong>Results: </strong>In female transgenic (AD) mice, gonadectomy resulted in poorer spatial learning performance. In contrast, in transgenic male animals, gonadectomy improved spatial learning and memory. Compared to sham-operated AD females, gonadectomized AD females exhibited enhanced expression of mouse (m) Mapt and App genes, consistent with reduced binding activity of the repressive histone variant macroH2A1 at the mMapt gene, but there was no effect on Aβ<sub>42</sub> or pTau181 levels. In contrast, gonadectomized AD males showed significantly increased macroH2A1 binding at the mPsen1 promoter, reduced expression of the App and MacroH2A1 genes, and reduced cortical soluble Aβ<sub>42</sub> levels compared to sham-operated AD males.</p><p><strong>Conclusions: </strong>In sum, the results suggest that reduction in serum levels of female gonadal hormones impairs spatial learning capacity, whereas loss of male gonadal hormones enhances spatial learning and memory. In females, gonadectomy reduces binding of the repressive histone variant MacroH2A1 to the mouse Mapt gene and increases expression of the mouse App and Mapt genes without affecting Aβ<sub>42</sub> or pTau181 levels. Conversely, loss of male gonadal hormones increases binding of MacroH2A1 to the mouse Psen1 gene and decreases App expression and Aβ<sub>42</sub> levels but has no effect on tau expression. Our work suggests that adult gonadal hormones contribute to sex differences in AD-like pathology and performance in learning and memory tasks. Moreover, sex-specific differences in AD-like pathology are partially due to the action of histone variants associated with neurodegeneration, such as macroH2A1.</p>","PeriodicalId":8890,"journal":{"name":"Biology of Sex Differences","volume":" ","pages":"7"},"PeriodicalIF":5.1,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12797355/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145653395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-26DOI: 10.1186/s13293-025-00785-6
Andrew D Chapp, Hannah M McMullan, Chau-Mi H Phan, Pramit P Jagtap, Mark J Thomas, Paul G Mermelstein
<p><strong>Background: </strong>Cocaine-induced changes in nucleus accumbens shell (NAcSh) medium spiny neurons (MSNs) differ based on dopamine receptor subtype expression, the sex of the animal, and for females, phase of the estrous cycle. These findings highlight the need to account for both sex and estrous cycle when studying drug-mediated alterations in neurophysiology. Whether MSNs of the nucleus accumbens core (NAcC), which serve different aspects of reward function, will exhibit similar sex and estrous cycle effects with cocaine administration was investigated.</p><p><strong>Methods: </strong>Mice underwent a 5-day locomotor sensitization paradigm via daily cocaine administration (15 mg/kg, s.c.) followed by a 1- to 4-day drug-free abstinence period. We examined NAcC MSN excitability by obtaining ex vivo whole-cell recordings from differentially labeled dopamine D1-receptor expressing MSNs (D1R-MSNs) and dopamine D2-receptor expressing MSNs (D2R-MSNs) obtained from male mice or female mice that were either in estrus or diestrus.</p><p><strong>Results: </strong>In this mouse strain, male and female mice sensitized to cocaine to a similar degree. In males, there were no cocaine-induced changes in NAcC D1R-MSN or D2R-MSN excitability. When comparing MSN subtypes, D2R-MSNs exhibited greater excitability. In saline-treated females, D1R-MSN excitability fluctuated across the estrous cycle with increased excitability during estrus. Following cocaine, estrous cycle-dependent D1R-MSN excitability was arrested, fixed at an intermediate value between estrus and diestrus when compared to saline controls. D2R-MSNs did not change across the estrous cycle or following cocaine. When comparing MSN subtypes, in diestrus, D2R-MSNs were more excitable under saline conditions, but indistinguishable from D1R-MSNs following cocaine. In contrast, during estrus, D1R- was indistinguishable from D2R-MSN excitability in saline treated animals, but with cocaine, D2R-MSNs displayed heightened excitability.</p><p><strong>Conclusions: </strong>There are fundamental sex differences in cocaine-induced changes to the excitability of D1R-MSNs in the NAcC. After cocaine exposure, female mice in diestrus saw a significant main effect change in MSN excitability, an inversion of what had previously been demonstrated in the NAcSh. These data suggest that there are fundamental sex differences in the neuropharmacological effect of cocaine in males versus females that are shell- and core-specific.</p><p><strong>Highlights: </strong>There are sex- and estrous-cycle dependent changes to D1R-MSNs in the NAcC that are sensitive to cocaine exposure. In males, cocaine has no effect on altering D1R- or D2R- MSNs excitability. During the estrous cycle, D1R-MSNs exhibit increased excitability during estrus. This fluctuation is halted by cocaine, such that D1R-MSNs recorded in diestrus show increased excitability following cocaine exposure whereas female D1R-MSNs recorded in estrus have decre
{"title":"Fundamental sex differences in cocaine-induced plasticity of D1R- and D2R-MSNs in the mouse nucleus accumbens core.","authors":"Andrew D Chapp, Hannah M McMullan, Chau-Mi H Phan, Pramit P Jagtap, Mark J Thomas, Paul G Mermelstein","doi":"10.1186/s13293-025-00785-6","DOIUrl":"10.1186/s13293-025-00785-6","url":null,"abstract":"<p><strong>Background: </strong>Cocaine-induced changes in nucleus accumbens shell (NAcSh) medium spiny neurons (MSNs) differ based on dopamine receptor subtype expression, the sex of the animal, and for females, phase of the estrous cycle. These findings highlight the need to account for both sex and estrous cycle when studying drug-mediated alterations in neurophysiology. Whether MSNs of the nucleus accumbens core (NAcC), which serve different aspects of reward function, will exhibit similar sex and estrous cycle effects with cocaine administration was investigated.</p><p><strong>Methods: </strong>Mice underwent a 5-day locomotor sensitization paradigm via daily cocaine administration (15 mg/kg, s.c.) followed by a 1- to 4-day drug-free abstinence period. We examined NAcC MSN excitability by obtaining ex vivo whole-cell recordings from differentially labeled dopamine D1-receptor expressing MSNs (D1R-MSNs) and dopamine D2-receptor expressing MSNs (D2R-MSNs) obtained from male mice or female mice that were either in estrus or diestrus.</p><p><strong>Results: </strong>In this mouse strain, male and female mice sensitized to cocaine to a similar degree. In males, there were no cocaine-induced changes in NAcC D1R-MSN or D2R-MSN excitability. When comparing MSN subtypes, D2R-MSNs exhibited greater excitability. In saline-treated females, D1R-MSN excitability fluctuated across the estrous cycle with increased excitability during estrus. Following cocaine, estrous cycle-dependent D1R-MSN excitability was arrested, fixed at an intermediate value between estrus and diestrus when compared to saline controls. D2R-MSNs did not change across the estrous cycle or following cocaine. When comparing MSN subtypes, in diestrus, D2R-MSNs were more excitable under saline conditions, but indistinguishable from D1R-MSNs following cocaine. In contrast, during estrus, D1R- was indistinguishable from D2R-MSN excitability in saline treated animals, but with cocaine, D2R-MSNs displayed heightened excitability.</p><p><strong>Conclusions: </strong>There are fundamental sex differences in cocaine-induced changes to the excitability of D1R-MSNs in the NAcC. After cocaine exposure, female mice in diestrus saw a significant main effect change in MSN excitability, an inversion of what had previously been demonstrated in the NAcSh. These data suggest that there are fundamental sex differences in the neuropharmacological effect of cocaine in males versus females that are shell- and core-specific.</p><p><strong>Highlights: </strong>There are sex- and estrous-cycle dependent changes to D1R-MSNs in the NAcC that are sensitive to cocaine exposure. In males, cocaine has no effect on altering D1R- or D2R- MSNs excitability. During the estrous cycle, D1R-MSNs exhibit increased excitability during estrus. This fluctuation is halted by cocaine, such that D1R-MSNs recorded in diestrus show increased excitability following cocaine exposure whereas female D1R-MSNs recorded in estrus have decre","PeriodicalId":8890,"journal":{"name":"Biology of Sex Differences","volume":"16 1","pages":"102"},"PeriodicalIF":5.1,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12659347/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145628752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Background: </strong>Drug metabolism va-specific dosing. Strychnine, the primary active compound in strychnine-based alkaloids, is used for treatment of hemiplegia or amblyopia. However, knowledge of sex-based difference in the pharmacokinetics of strychnine remains limited, increasing the risk of dosage error and potential toxicity in patient.ries between men and women derived from the difference in body fat distribution and hormone secretion, necessitating sex.</p><p><strong>Method: </strong>Rats were divided into intact (possessing reproductive organ) and gonadectomized (GDX) groups, including 6 males and 6 females in each one. In the GDX rat group, testes were removed from male rat at 5 weeks of age, while ovaries were removed from female rat. The GDX rats were maintained for an additional 15 days. All intact and GDX rats were tested at 8 weeks of age. Both intact and GDX rats were subjected to acute strychnine exposure through an oral dose of 0.59 mg/kg aqueous strychnine nitrate solution. Blood sampleswere collected from orbital vein into a centrifuge tube containing sodium heparin at following time points: 5, 10, 15, 30, and 45 min, as well as 1, 1.5, 2, 4, 6, 8, 12, 24, and 48 h. In the metabolomics experiments, male and female rats were divided into experimental and control groups. Each group containing 10 males and 10 females. The experimental group was orally administered 0.59 mg/kg of aqueous strychnine nitrate, while the control group was given the same dose of ultrapure water. Blood samples were collected from the orbital vein at 30 min, 2 h, and 12 h following administration. The plasma concentration of strychnine was quantified using high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS), while the metabolic kinetics data was acquired via HPLC-time-of-flight mass spectrometry (HPLC-TOF-MS). These data was subsequently analyzed to elucidate the intrinsic sex-specific metabolic difference between male and female rats.</p><p><strong>Result: </strong>Intact female rats metabolized strychnine more slowly than male rats, with significantly higher peak plasma concentrations. Moreover, the peak concentrations in both male and female rats decreased after gonadectomy, the plasma peak concentration in GDX female rats remained significantly higher than that in GDX male rats.The metabolic profile of the rat changed significantly after gonadectomy, suggesting that sex hormones may be involved in the metabolism of strychnine. Significant differences were also observed between the metabolomics of male and female rats, such as ABC transporter expression, pyrimidine metabolism, and linoleic acid metabolism pathways.</p><p><strong>Conclusion: </strong>Significant sex-specific difference exists between strychnine pharmacokinetics and metabolomics of male and female rats, potentially due to the differential expression of ABC transporter expression, pyrimidine metabolism and linoleic acid metabolism. These findings prov
{"title":"Analysis of sex difference in strychnine-intoxicated rat based on the combination of metabolic kinetics and metabolomics.","authors":"Wen Zhang, Chaoren Wang, Haiyun Liu, Sitong Nan, Fenglin Zhang, Congying Liu, Jiangwei Yan, Juan Jia","doi":"10.1186/s13293-025-00784-7","DOIUrl":"10.1186/s13293-025-00784-7","url":null,"abstract":"<p><strong>Background: </strong>Drug metabolism va-specific dosing. Strychnine, the primary active compound in strychnine-based alkaloids, is used for treatment of hemiplegia or amblyopia. However, knowledge of sex-based difference in the pharmacokinetics of strychnine remains limited, increasing the risk of dosage error and potential toxicity in patient.ries between men and women derived from the difference in body fat distribution and hormone secretion, necessitating sex.</p><p><strong>Method: </strong>Rats were divided into intact (possessing reproductive organ) and gonadectomized (GDX) groups, including 6 males and 6 females in each one. In the GDX rat group, testes were removed from male rat at 5 weeks of age, while ovaries were removed from female rat. The GDX rats were maintained for an additional 15 days. All intact and GDX rats were tested at 8 weeks of age. Both intact and GDX rats were subjected to acute strychnine exposure through an oral dose of 0.59 mg/kg aqueous strychnine nitrate solution. Blood sampleswere collected from orbital vein into a centrifuge tube containing sodium heparin at following time points: 5, 10, 15, 30, and 45 min, as well as 1, 1.5, 2, 4, 6, 8, 12, 24, and 48 h. In the metabolomics experiments, male and female rats were divided into experimental and control groups. Each group containing 10 males and 10 females. The experimental group was orally administered 0.59 mg/kg of aqueous strychnine nitrate, while the control group was given the same dose of ultrapure water. Blood samples were collected from the orbital vein at 30 min, 2 h, and 12 h following administration. The plasma concentration of strychnine was quantified using high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS), while the metabolic kinetics data was acquired via HPLC-time-of-flight mass spectrometry (HPLC-TOF-MS). These data was subsequently analyzed to elucidate the intrinsic sex-specific metabolic difference between male and female rats.</p><p><strong>Result: </strong>Intact female rats metabolized strychnine more slowly than male rats, with significantly higher peak plasma concentrations. Moreover, the peak concentrations in both male and female rats decreased after gonadectomy, the plasma peak concentration in GDX female rats remained significantly higher than that in GDX male rats.The metabolic profile of the rat changed significantly after gonadectomy, suggesting that sex hormones may be involved in the metabolism of strychnine. Significant differences were also observed between the metabolomics of male and female rats, such as ABC transporter expression, pyrimidine metabolism, and linoleic acid metabolism pathways.</p><p><strong>Conclusion: </strong>Significant sex-specific difference exists between strychnine pharmacokinetics and metabolomics of male and female rats, potentially due to the differential expression of ABC transporter expression, pyrimidine metabolism and linoleic acid metabolism. These findings prov","PeriodicalId":8890,"journal":{"name":"Biology of Sex Differences","volume":"16 1","pages":"100"},"PeriodicalIF":5.1,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12648864/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145602046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-25DOI: 10.1186/s13293-025-00757-w
Michelle Binod, Lin Chang, Ming Wei Hung, Tien S Dong, Lisa A Kilpatrick, Anthony Tomasevic, Michelle Choy, Andrea Shin, Emeran A Mayer, Arpana Church
Background: The brain-gut system, which involves bidirectional communication between the central nervous system and the gut, plays a central role in stress responses. Its dysregulation is implicated in irritable bowel syndrome (IBS), a stress-sensitive, female-predominant disorder characterized by abdominal pain and altered bowel habits. Adverse childhood experiences (ACE) increase the risk and severity of IBS, likely by amplifying stress responsiveness and gut-brain dysfunction in females. However, the mechanisms involved are unknown.
Aim: This study aimed to identify a multi-omic signature linking ACE exposure to IBS females via clinical, neuroimaging, and gut microbiome features as compared to healthy control (HC) females.
Methods: Data was analyzed from participants with Rome positive IBS and HCs. Four subgroups were created based on IBS diagnosis and ACE score with high ACE defined as ≥2 and low as ACE 0-1. Validated questionnaires assessed clinical variables. Biological markers included multimodal brain MRI, and gut microbial function using metagenomics. eXtreme gradient boosting (XGBoost) identified key differentiating features between the groups. Connectograms visualized relationships across mutli-omics data within each group.
Results: Among 188 female participants, the four groups included IBS with high ACE (n=37), IBS with low ACE (n=55), HCs with high ACE (n=19), and HCs with low ACE (n=77). Key findings include: 1. High ACE participants with IBS versus their HC counterparts showed increased depression and anxiety symptoms, GI-symptom related anxiety, perceived stress, somatic symptom severity, and poorer physical and mental health scores. 2. High ACE participants with IBS had negative associations between key bacteria such as Akkermansia (a beneficial bacteria) and somatic symptom severity, and between Bifidobacterium and ACE parental divorce/separation and alterations in the salience and central autonomic networks. 3. The ensemble model accurately distinguished IBS patients with high ACE (AUC of 0.87), demonstrating strong predictive performance with an overall model accuracy of 78%.
Conclusions: Our findings highlight the unique microbiota and brain networks contributing to a complex interplay of chronic stress as measured by early life adversity, the brain-gut-microbiome system, and IBS pathophysiology which can inform therapeutic targets aimed at mitigating the long-term impacts of early life stress in female IBS patients.
{"title":"Multi-omics analysis reveal clinical-gut-brain interactions in female ibs patients with adverse childhood experiences.","authors":"Michelle Binod, Lin Chang, Ming Wei Hung, Tien S Dong, Lisa A Kilpatrick, Anthony Tomasevic, Michelle Choy, Andrea Shin, Emeran A Mayer, Arpana Church","doi":"10.1186/s13293-025-00757-w","DOIUrl":"10.1186/s13293-025-00757-w","url":null,"abstract":"<p><strong>Background: </strong>The brain-gut system, which involves bidirectional communication between the central nervous system and the gut, plays a central role in stress responses. Its dysregulation is implicated in irritable bowel syndrome (IBS), a stress-sensitive, female-predominant disorder characterized by abdominal pain and altered bowel habits. Adverse childhood experiences (ACE) increase the risk and severity of IBS, likely by amplifying stress responsiveness and gut-brain dysfunction in females. However, the mechanisms involved are unknown.</p><p><strong>Aim: </strong>This study aimed to identify a multi-omic signature linking ACE exposure to IBS females via clinical, neuroimaging, and gut microbiome features as compared to healthy control (HC) females.</p><p><strong>Methods: </strong>Data was analyzed from participants with Rome positive IBS and HCs. Four subgroups were created based on IBS diagnosis and ACE score with high ACE defined as ≥2 and low as ACE 0-1. Validated questionnaires assessed clinical variables. Biological markers included multimodal brain MRI, and gut microbial function using metagenomics. eXtreme gradient boosting (XGBoost) identified key differentiating features between the groups. Connectograms visualized relationships across mutli-omics data within each group.</p><p><strong>Results: </strong>Among 188 female participants, the four groups included IBS with high ACE (n=37), IBS with low ACE (n=55), HCs with high ACE (n=19), and HCs with low ACE (n=77). Key findings include: 1. High ACE participants with IBS versus their HC counterparts showed increased depression and anxiety symptoms, GI-symptom related anxiety, perceived stress, somatic symptom severity, and poorer physical and mental health scores. 2. High ACE participants with IBS had negative associations between key bacteria such as Akkermansia (a beneficial bacteria) and somatic symptom severity, and between Bifidobacterium and ACE parental divorce/separation and alterations in the salience and central autonomic networks. 3. The ensemble model accurately distinguished IBS patients with high ACE (AUC of 0.87), demonstrating strong predictive performance with an overall model accuracy of 78%.</p><p><strong>Conclusions: </strong>Our findings highlight the unique microbiota and brain networks contributing to a complex interplay of chronic stress as measured by early life adversity, the brain-gut-microbiome system, and IBS pathophysiology which can inform therapeutic targets aimed at mitigating the long-term impacts of early life stress in female IBS patients.</p>","PeriodicalId":8890,"journal":{"name":"Biology of Sex Differences","volume":"16 1","pages":"101"},"PeriodicalIF":5.1,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12648784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145601983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-24DOI: 10.1186/s13293-025-00791-8
Yunbin Zhang, Ping Ren, Zhuangfei Chen, Yu Fu
{"title":"Correction: Sex differences in the effects of 10 Hz and 40 Hz transcranial alternating current stimulation on spatial cognition in mice.","authors":"Yunbin Zhang, Ping Ren, Zhuangfei Chen, Yu Fu","doi":"10.1186/s13293-025-00791-8","DOIUrl":"10.1186/s13293-025-00791-8","url":null,"abstract":"","PeriodicalId":8890,"journal":{"name":"Biology of Sex Differences","volume":"16 1","pages":"99"},"PeriodicalIF":5.1,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12641945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145595664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-23DOI: 10.1186/s13293-025-00793-6
Shelby Marozoff, Yannan Li, Nadia Mithani, Gabriela Kuczynski, Mohammad Ehsanul Karim, Arminee Kazanjian, Trevor J B Dummer
Many systematic reviews have summarized evidence on the association between behavioural factors and incident cancers. To date, there has been little synthesis of heterogeneity by sex/gender of this evidence.An umbrella review was conducted of systematic reviews with quantitative synthesis (meta-analysis, meta-regression) examining the exposures of body size; physical activity; wholegrains, vegetables, fruit and beans; "fast foods"; red and processed meat; sugar sweetened drinks; dietary supplements; alcohol; tobacco; and sun exposure with incident non-sex-specific cancers. A search of Ovid MEDLINE, Ovid Embase, and Cochrane library from database inception to May 2023 was conducted. We calculated the proportion of systematic reviews that provided quantitative sex/gender findings (e.g., subgroup analyses) and summarized findings narratively. Methodological quality was appraised with the AMSTAR-2 tool.From 13,227 records, 705 full-text systematic reviews were identified as meeting inclusion criteria. Of these, 361 (51.2%) reported quantitative sex/gender findings. The terms "sex" and "gender" were used interchangeably by 36.3% of the 361 systematic reviews and none reported findings for transgender, gender-diverse, or non-binary individuals. Overall, 98.6% (356/361) of systematic reviews were rated "critically low" with the AMSTAR-2 tool. Most of the 361 systematic reviews with quantitative sex/gender findings reported no statistically significant differences by sex/gender.This umbrella review found conflation of sex and gender in systematic reviews of behavioural factors and non-sex-specific cancers and a lack of research among non-cisgender individuals. The existing evidence base is of critically low quality and our findings of no sex/gender-specific trends must be interpreted with caution.
{"title":"Sex/gender differences in the association between behavioural factors and cancers: an umbrella review of systematic reviews with quantitative synthesis.","authors":"Shelby Marozoff, Yannan Li, Nadia Mithani, Gabriela Kuczynski, Mohammad Ehsanul Karim, Arminee Kazanjian, Trevor J B Dummer","doi":"10.1186/s13293-025-00793-6","DOIUrl":"10.1186/s13293-025-00793-6","url":null,"abstract":"<p><p>Many systematic reviews have summarized evidence on the association between behavioural factors and incident cancers. To date, there has been little synthesis of heterogeneity by sex/gender of this evidence.An umbrella review was conducted of systematic reviews with quantitative synthesis (meta-analysis, meta-regression) examining the exposures of body size; physical activity; wholegrains, vegetables, fruit and beans; \"fast foods\"; red and processed meat; sugar sweetened drinks; dietary supplements; alcohol; tobacco; and sun exposure with incident non-sex-specific cancers. A search of Ovid MEDLINE, Ovid Embase, and Cochrane library from database inception to May 2023 was conducted. We calculated the proportion of systematic reviews that provided quantitative sex/gender findings (e.g., subgroup analyses) and summarized findings narratively. Methodological quality was appraised with the AMSTAR-2 tool.From 13,227 records, 705 full-text systematic reviews were identified as meeting inclusion criteria. Of these, 361 (51.2%) reported quantitative sex/gender findings. The terms \"sex\" and \"gender\" were used interchangeably by 36.3% of the 361 systematic reviews and none reported findings for transgender, gender-diverse, or non-binary individuals. Overall, 98.6% (356/361) of systematic reviews were rated \"critically low\" with the AMSTAR-2 tool. Most of the 361 systematic reviews with quantitative sex/gender findings reported no statistically significant differences by sex/gender.This umbrella review found conflation of sex and gender in systematic reviews of behavioural factors and non-sex-specific cancers and a lack of research among non-cisgender individuals. The existing evidence base is of critically low quality and our findings of no sex/gender-specific trends must be interpreted with caution.</p>","PeriodicalId":8890,"journal":{"name":"Biology of Sex Differences","volume":" ","pages":"109"},"PeriodicalIF":5.1,"publicationDate":"2025-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12751745/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145586200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-17DOI: 10.1186/s13293-025-00782-9
Margrit Shildrick
{"title":"Microchimerism and the need to rethink sex and gender binaries.","authors":"Margrit Shildrick","doi":"10.1186/s13293-025-00782-9","DOIUrl":"10.1186/s13293-025-00782-9","url":null,"abstract":"","PeriodicalId":8890,"journal":{"name":"Biology of Sex Differences","volume":"16 1","pages":"98"},"PeriodicalIF":5.1,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12625259/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145538969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-12DOI: 10.1186/s13293-025-00779-4
Marcis V Scroger, Alexandria C Athanason, Noah M Paperny, Andrea Liss, Katie T Vo, Misha Muneeb, Mahum T Siddiqi, Molly R Batchelder, Iman Shahbaz, Serena Chan, Molly M Deak, Anushree N Karkhanis, Florence P Varodayan
<p><strong>Background: </strong>Norepinephrine (noradrenaline; NE) is a stress signal released from the locus coeruleus (LC) into the prefrontal cortex (PFC) to govern arousal, attention, and cognition. The LC is sexually dimorphic, and PFC NE dysfunction contributes to alcohol use disorder and several stress-related neuropsychiatric disorders that manifest differently in men and women. However, most preclinical studies of the medial PFC (mPFC) NE system have only used male subjects. Additionally, even though each mPFC subregion and layer forms unique circuits that mediate different aspects of cognitive behavior, their specific neuromodulation by NE is not understood.</p><p><strong>Methods: </strong>We comprehensively probed potential sex differences in the mouse mPFC NE system, starting with fluorescent tracing of the LC→mPFC circuit. Basal mPFC NE tissue content and adrenergic receptor mRNA were measured using high performance liquid chromatography and real-time quantitative polymerase chain reaction. Ex vivo electrophysiology assessed NE modulation of glutamate synapses in layers 2/3 and 5 of the prelimbic and infralimbic subregions of the mPFC. Finally, we used an α2 adrenergic receptor antagonist to increase NE release and tested for mPFC-associated reversal learning and episodic memory.</p><p><strong>Results: </strong>Females had a greater percentage of LC NE neurons→mPFC than males, with no differences in basal mPFC NE concentration or adrenergic receptor mRNA. NE increased mPFC glutamate release broadly in males, but its effects in females were restricted to prelimbic layer 5 and infralimbic layer 2/3. Finally, while there were dose-dependent effects of the α2 receptor antagonist on cognitive behavior, they did not vary between sexes.</p><p><strong>Conclusions: </strong>We uncovered complex sex differences in LC→mPFC structure and mPFC NE function, and future studies should examine NE activation in the context of greater cognitive load, such as during alcohol withdrawal or periods of stress. Clinically, women exhibit greater stress-induced activation of the NE system, are more likely to be diagnosed with affective disorders, and are more likely to drink alcohol to regulate negative affect and stress reactivity than men. Therefore, our study highlights the importance of considering specific subpopulations (e.g. women, or people with comorbid stress and alcohol use disorders) during the development of new NE-based treatments. Norepinephrine (also known as noradrenaline) is a stress signal that regulates activity in the brain region the medial prefrontal cortex (mPFC) to optimize decision making, emotional processing, inhibitory control, and learning and memory. Its dysfunction contributes to both alcohol use disorder and stress-related neuropsychiatric disorders, though its role may differ between men and women. It is well known that the brain region that makes norepinephrine (i.e. locus coeruleus; LC) is larger and more complex in women an
{"title":"Sex differences in noradrenergic regulation of the medial prefrontal cortex in mice.","authors":"Marcis V Scroger, Alexandria C Athanason, Noah M Paperny, Andrea Liss, Katie T Vo, Misha Muneeb, Mahum T Siddiqi, Molly R Batchelder, Iman Shahbaz, Serena Chan, Molly M Deak, Anushree N Karkhanis, Florence P Varodayan","doi":"10.1186/s13293-025-00779-4","DOIUrl":"10.1186/s13293-025-00779-4","url":null,"abstract":"<p><strong>Background: </strong>Norepinephrine (noradrenaline; NE) is a stress signal released from the locus coeruleus (LC) into the prefrontal cortex (PFC) to govern arousal, attention, and cognition. The LC is sexually dimorphic, and PFC NE dysfunction contributes to alcohol use disorder and several stress-related neuropsychiatric disorders that manifest differently in men and women. However, most preclinical studies of the medial PFC (mPFC) NE system have only used male subjects. Additionally, even though each mPFC subregion and layer forms unique circuits that mediate different aspects of cognitive behavior, their specific neuromodulation by NE is not understood.</p><p><strong>Methods: </strong>We comprehensively probed potential sex differences in the mouse mPFC NE system, starting with fluorescent tracing of the LC→mPFC circuit. Basal mPFC NE tissue content and adrenergic receptor mRNA were measured using high performance liquid chromatography and real-time quantitative polymerase chain reaction. Ex vivo electrophysiology assessed NE modulation of glutamate synapses in layers 2/3 and 5 of the prelimbic and infralimbic subregions of the mPFC. Finally, we used an α2 adrenergic receptor antagonist to increase NE release and tested for mPFC-associated reversal learning and episodic memory.</p><p><strong>Results: </strong>Females had a greater percentage of LC NE neurons→mPFC than males, with no differences in basal mPFC NE concentration or adrenergic receptor mRNA. NE increased mPFC glutamate release broadly in males, but its effects in females were restricted to prelimbic layer 5 and infralimbic layer 2/3. Finally, while there were dose-dependent effects of the α2 receptor antagonist on cognitive behavior, they did not vary between sexes.</p><p><strong>Conclusions: </strong>We uncovered complex sex differences in LC→mPFC structure and mPFC NE function, and future studies should examine NE activation in the context of greater cognitive load, such as during alcohol withdrawal or periods of stress. Clinically, women exhibit greater stress-induced activation of the NE system, are more likely to be diagnosed with affective disorders, and are more likely to drink alcohol to regulate negative affect and stress reactivity than men. Therefore, our study highlights the importance of considering specific subpopulations (e.g. women, or people with comorbid stress and alcohol use disorders) during the development of new NE-based treatments. Norepinephrine (also known as noradrenaline) is a stress signal that regulates activity in the brain region the medial prefrontal cortex (mPFC) to optimize decision making, emotional processing, inhibitory control, and learning and memory. Its dysfunction contributes to both alcohol use disorder and stress-related neuropsychiatric disorders, though its role may differ between men and women. It is well known that the brain region that makes norepinephrine (i.e. locus coeruleus; LC) is larger and more complex in women an","PeriodicalId":8890,"journal":{"name":"Biology of Sex Differences","volume":"16 1","pages":"97"},"PeriodicalIF":5.1,"publicationDate":"2025-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12613445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145501547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-11DOI: 10.1186/s13293-025-00770-z
Dayana Cabral-da-Silva, Ariane M Zanesco, Fernando Valdivieso-Rivera, Ana L Gallo-Ferraz, Marcela R Simões, Bruna Bombassaro, Carlos H Sponton, Licio A Velloso
Background: Brain-derived neurotrophic factor (BDNF) is highly expressed in the hypothalamus where it exerts regulatory functions over neurogenesis, reproduction, energy balance, and metabolism. Analyzing a hypothalamic single-nucleus transcriptomic, we identified Fezf1 ventromedial hypothalamic (VMH) neurons as an important source of BDNF. During development, Fezf1 neurons are involved in the organization of the olfactory bulb, and mutations on this gene are responsible for Kallmann syndrome; however, in adult life, little is known about the functions of Fezf1 neurons.
Methods: In this study, we aimed at providing advance in the characterization of Fezf1 neurons and exploring the role of Fezf1-BDNF in the regulation of the metabolic phenotype of mice. Hypothalamic immunofluorescence was employed to determine the distribution and projections of Fezf1 neurons. Mice with a Fezf1-specific knockout of BDNF were constructed and used in the determination of the metabolic phenotype.
Results: Using a Cre-Lox system to express mCherry specifically in Fezf1 neurons of the VMH, we identified projections to the dorsomedial hypothalamus and the zona incerta, regions involved in metabolic control and motor activity, respectively. The Fezf1-specific knockout of BDNF resulted in increased cold tolerance in males, and protection against diet-induced obesity due to a reduction in food intake and increased spontaneous ambulatory activity in females. This was accompanied by protection against glucose intolerance, and increased insulin sensitivity, in females.
Conclusions: Thus, the present work provides advance in the understanding of the biology of VMH Fezf1 neurons, revealing the details of its distribution and projections, and demonstrating that the expression of BDNF in these neurons is involved, according to a sexual dimorphic pattern, in the regulation of metabolic function. In addition, this is the first evidence that, in a specific hypothalamic cell population, BDNF may have a detrimental rather than positive role in the regulation of systemic metabolism.
{"title":"Metabolic sexual dimorphism in hypothalamic Fezf1 neuron-specific BDNF knockout.","authors":"Dayana Cabral-da-Silva, Ariane M Zanesco, Fernando Valdivieso-Rivera, Ana L Gallo-Ferraz, Marcela R Simões, Bruna Bombassaro, Carlos H Sponton, Licio A Velloso","doi":"10.1186/s13293-025-00770-z","DOIUrl":"10.1186/s13293-025-00770-z","url":null,"abstract":"<p><strong>Background: </strong>Brain-derived neurotrophic factor (BDNF) is highly expressed in the hypothalamus where it exerts regulatory functions over neurogenesis, reproduction, energy balance, and metabolism. Analyzing a hypothalamic single-nucleus transcriptomic, we identified Fezf1 ventromedial hypothalamic (VMH) neurons as an important source of BDNF. During development, Fezf1 neurons are involved in the organization of the olfactory bulb, and mutations on this gene are responsible for Kallmann syndrome; however, in adult life, little is known about the functions of Fezf1 neurons.</p><p><strong>Methods: </strong>In this study, we aimed at providing advance in the characterization of Fezf1 neurons and exploring the role of Fezf1-BDNF in the regulation of the metabolic phenotype of mice. Hypothalamic immunofluorescence was employed to determine the distribution and projections of Fezf1 neurons. Mice with a Fezf1-specific knockout of BDNF were constructed and used in the determination of the metabolic phenotype.</p><p><strong>Results: </strong>Using a Cre-Lox system to express mCherry specifically in Fezf1 neurons of the VMH, we identified projections to the dorsomedial hypothalamus and the zona incerta, regions involved in metabolic control and motor activity, respectively. The Fezf1-specific knockout of BDNF resulted in increased cold tolerance in males, and protection against diet-induced obesity due to a reduction in food intake and increased spontaneous ambulatory activity in females. This was accompanied by protection against glucose intolerance, and increased insulin sensitivity, in females.</p><p><strong>Conclusions: </strong>Thus, the present work provides advance in the understanding of the biology of VMH Fezf1 neurons, revealing the details of its distribution and projections, and demonstrating that the expression of BDNF in these neurons is involved, according to a sexual dimorphic pattern, in the regulation of metabolic function. In addition, this is the first evidence that, in a specific hypothalamic cell population, BDNF may have a detrimental rather than positive role in the regulation of systemic metabolism.</p>","PeriodicalId":8890,"journal":{"name":"Biology of Sex Differences","volume":"16 1","pages":"95"},"PeriodicalIF":5.1,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12606896/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145494439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}